Fund Holdings — ADAR1 Capital Management, LLC

Total Portfolio Value:
$519.71M
Total Bought:
$149.85M
Total Sold:
$103.39M
Net Transaction:
+$46.46M
Notable People:
Daniel Pawel Schneeberger, Adar1 Capital Management Gp, Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Protagonist Therapeutics Inc1,020,333939,669-80,664$39.38M$45.44M8.74%+$6.06M
Ea Series TrustALPHA ARCH 1 3
ALPHA ARCH 1-3
325,450337,125+11,675$35.89M$37.59M7.23%+$1.70M
Roivant Sciences Ltd.SHS(ROIV)3,508,6943,483,404-25,290$41.51M$35.15M6.76%-$6.36M
Zai Lab LimitedADR(ZLAB)1,045,837940,858-104,979$27.39M$34.00M6.54%+$6.61M
Immunovant, Inc.(IMVT)787,478968,866+181,388$19.51M$16.56M3.19%-$2.95M
Cytokinetics, Incorporated(CYTK)414,209390,729-23,480$19.48M$15.70M3.02%-$3.78M
Keros Therapeutics, Inc.(KROS)23,2461,486,461+1,463,215$368.0K$15.15M2.91%+$14.78M
ABIVAX Société AnonymeADS(ABVX)1,513,3932,210,019+696,626$11.08M$13.81M2.66%+$2.73M
Spdr Ser TrBLOOMBERG 1 3 MO
ST STR BLO 1 ETF
131,786135,585+3,799$12.05M$12.44M2.39%+$388.0K
BridgeBio Pharma, Inc.(BBIO)678,857339,635-339,222$18.63M$11.74M2.26%-$6.89M
Inhibikase Therapeutics, Inc.(IKT)5,103,0055,122,105+19,100$16.58M$11.22M2.16%-$5.37M
Springworks Therapeutics Inc0207,778+207,778$0$9.17M1.76%+$9.17M
Ishares Tr1 3 YR TREAS BD0103,337+103,337$0$8.55M1.64%+$8.55M
Teva Pharmaceutical Industries LimitedADS(TEVA)146,671523,767+377,096$3.23M$8.05M1.55%+$4.82M
Sarepta Therapeutics, Inc.(SRPT)40,002122,921+82,919$4.86M$7.84M1.51%+$2.98M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.63M$7.72M1.49%+$90.0K
CG Oncology, Inc.(CGON)215,750301,134+85,384$6.19M$7.37M1.42%+$1.19M
Rapt Therapeutics Inc1,174,3135,970,768+4,796,455$1.86M$7.28M1.40%+$5.43M
Arbutus Biopharma Corporation(ABUS)1,554,8021,879,114+324,312$5.08M$6.56M1.26%+$1.47M
Intra-Cellular Therapies Inc048,044+48,044$0$6.34M1.22%+$6.34M
Revolution Medicines, Inc.(RVMD)170,000177,136+7,136$7.44M$6.26M1.21%-$1.17M
Anteris Technologies Global Corp.(AVR)1,052,9681,678,063+625,095$5.88M$6.11M1.18%+$232.6K
Aa Mission Acquisition CorpCL A560,199578,359+18,160$5.66M$6.03M1.16%+$374.3K
Sage Therapeutics Inc19,200742,495+723,295$104.3K$5.90M1.14%+$5.80M
89bio Inc515,138804,220+289,082$4.03M$5.85M1.12%+$1.82M
Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS)000$5.48M$5.48M1.06%+$6.8K
Oaktree Acquisition Corp IiiUNIT 10 04 2029
UNIT 10/04/2029
500,000516,482+16,482$5.07M$5.39M1.04%+$327.1K
Helix Acquisition Corp IiCL A404,138469,729+65,591$4.24M$5.31M1.02%+$1.06M
Amylyx Pharmaceuticals, Inc.(AMLX)01,471,587+1,471,587$0$5.21M1.00%+$5.21M
Scholar Rock Holding Corporation(SRRK)19,505157,079+137,574$843.0K$5.05M0.97%+$4.21M
Xenon Pharmaceuticals Inc.(XENE)50,547127,548+77,001$1.98M$4.28M0.82%+$2.30M
Xencor, Inc.(XNCR)234,607398,152+163,545$5.39M$4.24M0.82%-$1.15M
Mineralys Therapeutics, Inc.(MLYS)841,541263,425-578,116$10.36M$4.18M0.80%-$6.18M
Septerna, Inc.(SEPN)0720,848+720,848$0$4.17M0.80%+$4.17M
Janux Therapeutics, Inc.(JANX)31,509153,767+122,258$1.69M$4.15M0.80%+$2.46M
BridgeBio Pharma, Inc.NOTE 2 250 2 0(BBIO)000$3.86M$4.03M0.78%+$173.3K
Apogee Therapeutics Inc41,274104,853+63,579$1.87M$3.92M0.75%+$2.05M
Savara Inc.(SVRA)988,4681,360,291+371,823$3.03M$3.77M0.73%+$733.4K
Monopar Therapeutics Inc.(MNPR)130,037100,774-29,263$2.86M$3.67M0.71%+$808.4K
Aerovate Therapeutics Inc928,0161,461,234+533,218$2.46M$3.67M0.71%+$1.21M
BioAge Labs, Inc.(BIOA)123,037971,100+848,063$712.4K$3.65M0.70%+$2.94M
Zura Bio LimitedCL A(ZURA)2,077,2512,801,184+723,933$5.19M$3.61M0.70%-$1.58M
Astria Therapeutics Inc90,984641,690+550,706$813.4K$3.43M0.66%+$2.61M
Rezolute, Inc.(RZLT)1,359,2081,116,047-243,161$6.66M$3.24M0.62%-$3.42M
Centessa Pharmaceuticals PlcADS154,027216,166+62,139$2.58M$3.11M0.60%+$528.5K
Akero Therapeutics Inc15,30771,143+55,836$425.8K$2.88M0.55%+$2.45M
Merus N V81,46066,960-14,500$3.43M$2.82M0.54%-$607.0K
Bridgebio Pharma IncNOTE 1 750 3 0000$0$2.74M0.53%+$2.74M
PTC Therapeutics, Inc.(PTCT)48,02350,023+2,000$2.17M$2.55M0.49%+$381.4K
REGENXBIO Inc.(RGNX)170,129350,352+180,223$1.32M$2.51M0.48%+$1.19M
Ardelyx Inc31,035490,743+459,708$157.3K$2.41M0.46%+$2.25M
BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO)000$2.10M$2.28M0.44%+$177.7K
Dynavax Technologies Corp0170,000+170,000$0$2.20M0.42%+$2.20M
Arvinas, Inc.(ARVN)0313,354+313,354$0$2.20M0.42%+$2.20M
A Spac Iii Acquisition CorpCL A
ORD SHS CL A
0215,000+215,000$0$2.16M0.42%+$2.16M
Rhythm Pharmaceuticals, Inc.(RYTM)30,94136,890+5,949$1.73M$1.95M0.38%+$222.0K
Delcath Systems, Inc.(DCTH)149,385149,3850$1.80M$1.90M0.37%+$103.1K
Crinetics Pharmaceuticals In53,12553,1250$2.72M$1.78M0.34%-$934.5K
KALA BIO, Inc.(KALA)220,373298,955+78,582$1.53M$1.71M0.33%+$183.6K
Vir Biotechnology, Inc.(VIR)64,067250,000+185,933$470.3K$1.62M0.31%+$1.15M
Rocket Pharmaceuticals, Inc.(RCKT)211,400241,800+30,400$2.66M$1.61M0.31%-$1.04M
Taysha Gene Therapies, Inc.(TSHA)177,7071,066,309+888,602$307.4K$1.48M0.29%+$1.17M
Viking Therapeutics, Inc.(VKTX)9,30059,413+50,113$374.2K$1.43M0.28%+$1.06M
Fulcrum Therapeutics, Inc.(FULC)196,248490,532+294,284$922.4K$1.41M0.27%+$490.4K
Cargo Therapeutics Inc0341,515+341,515$0$1.39M0.27%+$1.39M
Oruka Therapeutics, Inc.(ORKA)0132,780+132,780$0$1.36M0.26%+$1.36M
Soleno Therapeutics Inc36,83018,830-18,000$1.66M$1.35M0.26%-$310.1K
Verona Pharma PlcADS29,10020,000-9,100$1.35M$1.27M0.24%-$81.6K
Checkpoint Therapeutics Inc0305,800+305,800$0$1.24M0.24%+$1.24M
Aldeyra Therapeutics, Inc.(ALDX)647,960211,579-436,381$3.23M$1.22M0.23%-$2.02M
Korro Bio, Inc.(KRRO)57,97868,715+10,737$2.21M$1.20M0.23%-$1.01M
Contineum Therapeutics, Inc.CL A(CTNM)82,234168,765+86,531$1.20M$1.18M0.23%-$26.7K
Tectonic Therapeutic, Inc.(TECX)58,70862,603+3,895$2.71M$1.11M0.21%-$1.60M
Viridian Therapeutics, Inc.(VRDN)26,00079,000+53,000$498.4K$1.06M0.20%+$566.5K
Vistagen Therapeutics, Inc.(VTGN)121,461420,765+299,304$358.3K$1.05M0.20%+$693.6K
Pfizer Inc.(PFE)35,05041,050+6,000$929.9K$1.04M0.20%+$110.3K
Ares Acquisition Corp IiCL A138,96690,466-48,500$1.53M$1.01M0.19%-$517.2K
Surgery Partners, Inc.(SGRY)040,000+40,000$0$950.0K0.18%+$950.0K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)166,40641,412-124,994$3.29M$919.8K0.18%-$2.37M
Arcellx Inc
COMMON STOCK
3,96213,962+10,000$303.8K$915.9K0.18%+$612.1K
Regeneron Pharmaceuticals, Inc.(REGN)1,3611,3610$969.5K$863.2K0.17%-$106.3K
Keen Vision Acquisition CorporationUNIT 99 99 9999(KVACF)75,00075,0000$824.3K$841.5K0.16%+$17.3K
Agios Pharmaceuticals, Inc.(AGIO)027,900+27,900$0$817.5K0.16%+$817.5K
Grace Therapeutics, Inc.(GRCE)773,635343,512-430,123$2.89M$783.2K0.15%-$2.11M
Kezar Life Sciences Inc
COM NEW
147,404147,4040$990.6K$719.3K0.14%-$271.2K
Arrowhead Pharmaceuticals, Inc.(ARWR)12,90056,300+43,400$242.5K$717.3K0.14%+$474.7K
Structure Therapeutics IncADS35,31935,619+300$957.9K$616.6K0.12%-$341.3K
Biogen Inc.(BIIB)3,0454,500+1,455$465.6K$615.8K0.12%+$150.1K
Iteos Therapeutics Inc131,599101,096-30,503$1.01M$603.5K0.12%-$407.1K
Natera, Inc.(NTRA)04,250+4,250$0$601.0K0.12%+$601.0K
Zymeworks Inc.(ZYME)050,000+50,000$0$595.5K0.11%+$595.5K
Lexeo Therapeutics, Inc.(LXEO)169,505170,448+943$1.12M$591.5K0.11%-$523.9K
Kiora Pharmaceuticals, Inc.(KPRX)200,221194,665-5,556$660.7K$585.9K0.11%-$74.8K
Spero Therapeutics, Inc.(SPRO)801,277801,2770$825.3K$576.9K0.11%-$248.4K
Biohaven Ltd.(BHVN)022,641+22,641$0$544.3K0.10%+$544.3K
Protara Therapeutics, Inc.(TARA)122,690122,6900$647.8K$522.7K0.10%-$125.1K
WisdomTree, Inc.FLOATNG RAT TREA(WT)10,00010,0000$503.2K$503.3K0.10%+$100
Agriculture & Nat Sol Acq CoCL A
SHS CL A
80,36247,062-33,300$843.0K$502.1K0.10%-$340.9K
Eli Lilly and Company(LLY)1,350600-750$1.04M$495.5K0.10%-$546.7K
Madrigal Pharmaceuticals, Inc.(MDGL)01,490+1,490$0$493.5K0.09%+$493.5K
Page 1 of 3
ADAR1 Capital Management, LLC — 13F Holdings — Q1 2025 | TickerTrail